Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 10 - The Untold Story

Study of 2.5 Million U.S. Children Found No Link Between MMR Timing Before Age 2 and Autism

A cohort of 2.5 million US children found no association between first MMR dose timing before age 2 and later autism diagnosis. Here is what it shows.

Medical Daily · Aug 5

VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans

The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.

Medical Daily · Aug 4

Analysis of 19 Trials Finds GLP-1 Results Differ by Drug and Dose, Pointing Toward More Tailored Obesity Care

A 19-trial analysis found GLP-1 drugs and doses differ across seven heart and metabolic measures. It does not yet tell doctors which one to pick.

Medical Daily · Aug 4

From analysis to the latest developments in health,
read the most diverse news in one place.

VA Begins Enrolling 600 Veterans in Trial Testing Whether Semaglutide Reduces Alcohol Use

The VA launched a placebo-controlled trial of semaglutide for alcohol use disorder in 600 veterans. No results exist yet. Here is what it tests.

Medical Daily · Aug 4

Type 2 diabetes patients on metformin, take note: After 60 years, scientists find this drug has hidden effects on the brain

Diabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct brain pathway responsible for glucose regulation. Remarkably, researchers observed that a small dose significantly reduced blood sugar levels in mice. This groundbreaking finding has the potential to pave the way for…

The Economic Times · Aug 4

'Floaters' do not pose a risk to your eye health

Dear Doctors: I was recently diagnosed with "floaters" in my right eye. I am told it just happens and is not my diabetes or high blood pressure. The floaters are constant and only get better with sunglasses. They make eye-involved activities difficult, and I get somewhat carsick. Any suggestions?

Bangkok Post · Aug 3

Type 2 diabetes medicine widely used since 1922 may affect blood sugar patient's brain, claims recent study

Metformin may have been part of diabetes medicine for generations, but scientists are still uncovering new chapters in its story. The possibility that the brain participates in its glucose-lowering action is a reminder that the human body's metabolic system is deeply interconnected—and that even some of medicine's oldest tools can…

The Economic Times · Aug 3

Read news from The Economist, FT, and more,
with one subscription

What Is Retatrutide? The Next-Gen GLP-1 Poised to Become the Most In-Demand Peptide

A deep dive into Retatrutide shows promise—and a lot of danger.

Marie Claire · Aug 3

For GLP-1 users, the in-store clothes shopping trip is back

Many consumers using weight-loss drugs are now shopping more in physical stores. Sizing changes prompt shoppers to try on clothes, increasing in-store visits. Retailers are adapting their strategies to accommodate these evolving customer needs. Some businesses are enhancing styling services and fitting room experiences. This trend suggests a potential shift…

The Economic Times · Aug 2

Ultra-processed food companies hindering health drives by suing countries, says WHO

Exclusive: Director general accuses corporations of obstructing efforts to tackle obesity crisis after investigation by Guardian and others

The Guardian - UK · Aug 1

Employer Coverage for Weight-Loss Drugs Is Tightening for 2027, and the Summary of Benefits Is Where You Will Find Out

Large employers are narrowing GLP-1 weight-loss coverage for 2027. How to read your benefits summary and what to ask HR before open enrollment.

Medical Daily · Jul 31

Puberty blockers trial set to proceed in England after legal challenge thrown out

A clinical trial into the benefits and risks of puberty blockers in teenagers is set to proceed after a legal challenge over the trial was thrown…

The National (Scotland) · Jul 31

FDA Writes Non Medicated Erectile Dysfunction Gels into Federal Regulation with a Fixed Set of Testing Rules

FDA codified a Class II device category for non-medicated topical ED gels, fixing the testing and labeling rules any future product must meet.

Medical Daily · Jul 31

Three Medical Device Categories Established in 2023 Are Now Officially Codified by the FDA

FDA codified three device categories covering a kidney risk test, a diabetes therapy app, and at-home COVID tests. All were classified in 2023.

Medical Daily · Jul 31

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Jul 30

The US public is fed up with RFK Jr. To really ‘make America healthy again’, it should look to Europe

Americans are dying younger than Europeans, despite being the wealthiest people on the planet. Wellness fads won’t change that, says public health expert Devi Sridhar

Medical Daily · Jul 30

FDA Sets the Testing Standards Generic Weight Loss Injections Must Meet Before Approval

The FDA published 17 revised draft guidances setting testing expectations for generic peptide injections, including semaglutide and tirzepatide.

Medical Daily · Jul 29

GLP-1 Drugs Did Not Lower Relapse Risk in Crohn's and Colitis Patients, a Large Claims Analysis Found

A claims study found GLP-1 drugs did not reduce IBD relapse in patients with obesity or diabetes, and did not raise safety events.

Medical Daily · Jul 29

One Prediabetes Subgroup Kept Sliding Toward Diabetes Despite Years of Sustained Weight Loss

One prediabetes subgroup kept progressing toward diabetes despite sustained 8% weight loss and the steepest drop in insulin secretion.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger · Jul 29

GLP-1 Medicare Coverage: How to Get It for $50 (And the Catch)

A new CMS program finally brings Wegovy and Zepbound within reach for seniors. But a hidden rule about your deductible could cost you thousands.

The Economic Times · Jul 29

Think diet sweeteners are harmless? Here's how they alter gut-brain signalling

Artificial sweeteners, discovered by chance, offer temporary sugar relief for many individuals. Experts suggest long-term use can negatively affect insulin processing and increase cravings. Some sweeteners may interfere with brain hunger signals, leading to increased appetite. While reducing sugar intake is a short-term victory, long-term goals are crucial.

The Guardian - UK · Jul 28

Black people’s risk factors for stroke ‘rising faster than for white people’

Exclusive: King’s College London analysis finds diabetes and hypertension are more common in Black African and Caribbean people

Medical Daily · Jul 28

Millions Take Metformin Daily: Here Is What New Research Says About How It Actually Works

New research suggests metformin works mainly in the gut, not the liver. Here is the plain-language explanation and why nothing about your dosing changes.

The Independent UK · Jul 28

Three ultra-processed foods that can be beneficial for a healthy diet

A new study has found that avoiding ultra-processed foods entirely can lead to lower diet quality

Medical Daily · Jul 28

Does a Packaged Food Automatically Count as Unhealthy? A Harvard Analysis Says It Is More Complicated

A Harvard analysis of 200,000 adults found diet quality predicted disease risk better than food processing level. What that means in the grocery aisle.

Medical Daily · Jul 28

Daily Oral Weight Loss Pill Outperformed Oral Semaglutide On Weight And Blood Sugar In Type 2 Diabetes

In a 1,698-person trial, orforglipron beat oral semaglutide on A1C and weight in type 2 diabetes. Here is what was measured and what was not.

1 … 9 10 11 12

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vaccines for Children

58 stories

HRA

36 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.